S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Study protocol of LOGIK1605/JART-1501

被引：5

作者：

Fukuda, Minoru ^{[1
]}

Funaki, Soichiro ^{[2
]}

Yamazaki, Takuya ^{[3
]}

Sato, Shuntaro ^{[4
]}

Mukae, Hiroshi ^{[5
]}

Takenoyama, Mitsuhiro ^{[6
]}

Fukuoka, Junya ^{[7
]}

Nabeshima, Kazuki ^{[8
]}

Tateyama, Hisashi ^{[9
]}

Ashizawa, Kazuto ^{[10
]}

Hara, Masaki ^{[11
]}

Seto, Takashi ^{[6
]}

Okumura, Meinoshin ^{[12
,13
]}

Sugio, Kenji ^{[14
,15
]}

机构：

[1] Nagasaki Univ Hosp, Clin Oncol Ctr, 1-7-1 Sakamoto, Nagasaki 8528501, Japan

[2] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan

[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol, Nagasaki, Japan

[4] Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan

[5] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Med, Nagasaki, Japan

[6] Natl Hosp Org Kyusyu Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan

[7] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pathol, Nagasaki, Japan

[8] Fukuoka Univ, Dept Pathol, Fac Med, Fukuoka, Japan

[9] Kasugai Municipal Hosp, Dept Pathol, Kasugai, Aichi, Japan

[10] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oncol, Nagasaki, Japan

[11] Nagoya City West Med Ctr, Dept Radiol, Nagoya, Aichi, Japan

[12] Osaka Toneyama Med Ctr, Osaka, Japan

[13] JART, Osaka, Japan

[14] Oita Univ, Fac Med, Dept Thorac & Breast Surg, Oita, Japan

[15] LOGiK, Fukuoka, Japan

来源：

THORACIC CANCER | 2020年 / 11卷 / 03期

关键词：

Cisplatin; radiotherapy; S-1; thymic carcinoma; PHASE-II; CHEMOTHERAPY; CANCER;

D O I：

10.1111/1759-7714.13319

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Thymic carcinoma is a rare epithelial tumor of the thymus with a poor prognosis, and multimodal approaches are important for its treatment. Recently, a number of studies have indicated that S-1 treatment is effective against thymic carcinoma. S-1 plus cisplatin with concurrent radiotherapy is a commonly used treatment for other malignancies, including non-small cell lung cancer (NSCLC). In addition, its safety has been confirmed, and it has been reported to have a marked effect against thymic carcinoma. Therefore, we conducted a phase II study of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced thymic carcinoma, in which the overall response rate was employed as the primary endpoint. The secondary endpoints were overall survival, progression-free survival, and safety.

引用

页码：693 / 696

页数：4

共 50 条

[41] A multicenter phase II trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
Ioka, T.
Ikeda, M.
Ito, Y.
Yonemoto, N.
Nagase, M.
Yamao, K.
Miyakawa, H.
Sato, K.
Sato, T.
Okusaka, T.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[42] Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
Hee Man Kim
Seungmin Bang
Jeong Youp Park
Jinsil Seong
Si Young Song
Jae Bock Chung
Seung Woo Park
Cancer Chemotherapy and Pharmacology, 2009, 63 : 535 - 541
[43] Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer
Kim, Hee Man
Bang, Seungmin
Park, Jeong Youp
Seong, Jinsil
Song, Si Young
Chung, Jae Bock
Park, Seung Woo
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 535 - 541
[44] Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma (AGC).
Ajani, JA
Yao, J
Faust, J
Carr, K
Anbe, H
Houghton, M
Urrea, P
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 324S - 324S
[45] A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0501
Nogami, Naoyuki
Takigawa, Nagio
Hotta, Katsuyuki
Segawa, Yoshihiko
Kato, Yuka
Kozuki, Toshiyuki
Oze, Isao
Kishino, Daizo
Aoe, Keisuke
Ueoka, Hiroshi
Kuyama, Shoichi
Harita, Shingo
Okada, Toshiaki
Hosokawa, Shinobu
Inoue, Koji
Gemba, Kenichi
Shibayama, Takuo
Tabata, Masahiro
Takemoto, Mitsuhiro
Kanazawa, Susumu
Tanimoto, Mitsune
Kiura, Katsuyuki
LUNG CANCER, 2015, 87 (02) : 141 - 147
[46] Preoperative concurrent chemotherapy with S-1 and radiotherapy for locally advanced squamous cell carcinoma of the oral cavity: Phase I trial
Harada, Hiroyuki
Omura, Ken
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
[47] Preoperative concurrent chemotherapy with S-1 and radiotherapy for locally advanced squamous cell carcinoma of the oral cavity: Phase I trial
Hiroyuki Harada
Ken Omura
Journal of Experimental & Clinical Cancer Research, 29
[48] S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma Study protocol for a randomized controlled phase II trial
Wen, Yixue
Zhao, Zhenhuan
Miao, Jidong
Yang, Qilin
Gui, Yan
Sun, Mingqiang
Tian, Honggang
Jia, Qiang
Liao, Dongbiao
Yang, Chen
Du, Xiaobo
MEDICINE, 2017, 96 (49)
[49] Comparative study of cisplatin-based definitive concurrent chemoradiotherapy with S-1 versus paclitaxel for unresectable locally advanced esophageal squamous cell carcinoma
Fang, Min
Song, Tao
Liang, Xiaodong
Lv, Shiliang
Li, Jianbo
Xu, Hong'en
Luo, Limin
Jia, Yongshi
ONCOTARGET, 2017, 8 (23) : 37080 - 37090
[50] IMRT Combined with Concurrent S-1 Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma: A Prospective Phase II Study
Lv, T.
Wang, X.
Wang, Y.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S199 - S200

← 1 2 3 4 5 →